Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...

Atea Pharmaceuticals (AVIR) offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines advantages of current first-line HCV therapies — single ...

Common HIV and cancer medications damage brain cell functions (lipid imbalance), contributing to cognitive decline. Need for ...

Using Machine Learning Methods to Predict Early Treatment Outcomes for Multidrug-Resistant or Rifampicin-Resistant Tuberculosis to Enhance Patient Cure Rates: Development and Validation of Multiple ...

Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...

A few decades ago, the idea of an HIV cure sounded unrealistic. Today, doctors describe a carefully documented case where the ...

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their blood. Yet that reality is limited to ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

Researchers at Johns Hopkins Medicine have reported evidence that standard chemotherapeutic drugs may selectively suppress ...

Researchers at Johns Hopkins have found that chemotherapy drugs paclitaxel and carboplatin, used to treat cancer patients, ...

Forty years after he became one of the area's first AIDS deaths, Rick Rapaport's impact on the community remains.

Specific, reliable data on the prevalence of using non-prescribed ART or self-medicating for confirmed HIV infection among ...